ProQR Therapeutics (PRQR) Operating Income Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 5.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.91% |
| Sep 30, 2025 | 12.93% |
| Jun 30, 2025 | 6.37% |
| Mar 31, 2025 | 15.90% |
| Dec 31, 2024 | 18.39% |
| Sep 30, 2024 | 17.69% |
| Jun 30, 2024 | 37.53% |
| Mar 31, 2024 | 15.62% |
| Dec 31, 2023 | 21.44% |
| Sep 30, 2023 | 14.09% |
| Jun 30, 2023 | -37.39% |
| Mar 31, 2023 | 17.87% |
| Dec 31, 2022 | 12.97% |
| Sep 30, 2022 | -10.13% |
| Jun 30, 2022 | -8.30% |
| Mar 31, 2022 | -4.52% |
| Dec 31, 2021 | -10.57% |
| Sep 30, 2021 | -35.61% |
| Jun 30, 2021 | -20.22% |
| Mar 31, 2021 | -26.02% |
| Dec 31, 2020 | -45.83% |
| Sep 30, 2020 | -26.02% |
| Jun 30, 2020 | 30.86% |
| Mar 31, 2020 | -54.91% |
| Dec 31, 2019 | -20.31% |
| Sep 30, 2019 | -10.73% |
| Jun 30, 2019 | -3.45% |
| Mar 31, 2019 | -19.90% |
| Dec 31, 2018 | -21.09% |
| Sep 30, 2018 | 0.42% |
| Jun 30, 2018 | -8.65% |
| Mar 31, 2018 | 1,067.46% |
| Dec 31, 2017 | 59.22% |
| Sep 30, 2017 | 1,109.37% |
| Mar 31, 2017 | 83.35% |
| Dec 31, 2016 | -71.43% |
| Sep 30, 2016 | -111.27% |